Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | FGF23 | Q9GZV9 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | DHODH | Q02127 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2762278 | 0.97 | FGF23 (0.35) | CES1MEN1KMT2AFGF23KDM4E | |
| SCHEMBL27171020 | 0.90 | FGF23 (0.30) | FGF23 | |
| SCHEMBL17180472 | 0.85 | MEN1 (0.31) | MEN1KMT2A | |
| SCHEMBL4191656 | 0.81 | TSHR (0.32) | KDM4E | |
| SCHEMBL29776024 | 0.81 | BRD4 (0.35) | CES1MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL3693341 | 0.81 | BRD4 (0.35) | CES1MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL29595700 | 0.79 | FGF23 (0.32) | MEN1KMT2AFGF23KDM4E | |
| SCHEMBL22776383 | 0.79 | FGF23 (0.32) | MEN1KMT2AFGF23KDM4E | |
| SCHEMBL27171026 | 0.78 | — | — | |
| SCHEMBL180041 | 0.78 | FGF23 (0.31) | FGF23 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12065560-B2 | Propylene-ethylene random copolymer | LG CHEM, LTD. (KR) | 2024-08-20 | — | — | US | disclosed |
| EP-3936542-B1 | PROPYLENE-ETHYLENE RANDOM COPOLYMER | LG CHEMICAL LTD (KR) | 2023-11-08 | — | — | EP | disclosed |
| CN-113840845-B | Propylene-ethylene random copolymer | 株式会社LG化学 | 2023-08-18 | — | — | CN | disclosed |
| US-20220213303-A1 | Propylene-Ethylene Random Copolymer | LG CHEM, LTD. (KR) | 2022-07-07 | — | — | US | disclosed |
| EP-3936542-A1 | PROPYLENE-ETHYLENE RANDOM COPOLYMER | LG CHEM, LTD. (KR) | 2022-01-12 | — | — | EP | disclosed |
| CN-113840845-A | Propylene-ethylene random copolymer | 株式会社LG化学 | 2021-12-24 | — | — | CN | disclosed |
| WO-2020251264-A1 | PROPYLENE-ETHYLENE RANDOM COPOLYMER | 주식회사 엘지화학 | 2020-12-17 | — | — | WO | disclosed |
| EP-1692144-B1 | ORGANOMETALLIC TRANSITION METAL COMPOUND, BISCYCLOPENTADIENYL LIGAND SYSTEM, CATALYST SYSTEM AND PREPARATION OF POLYOLEFINS | BASELL POLYOLEFINE GMBH (DE) | 2010-04-14 | — | — | EP | disclosed |
| US-7452949-B2 | Organometallic transition metal compound, biscyclopentadienyl ligand system, catalyst system and preparation of polyolefins | BASELL POLYOLEFINE GMBH (DE) | 2008-11-18 | — | — | US | disclosed |
| US-20070155919-A1 | Organometallic transition metal compound, biscyclopentadienyl ligand system, catalyst system and preparation of polyolefins | BASELL POLYOLEFINE GMBH (DE) | 2007-07-05 | — | — | US | disclosed |
| EP-1692144-A2 | ORGANOMETALLIC TRANSITION METAL COMPOUND, BISCYCLOPENTADIENYL LIGAND SYSTEM, CATALYST SYSTEM AND PREPARATION OF POLYOLEFINS | Basell Polyolefine GmbH (DE) | 2006-08-23 | — | — | EP | disclosed |
| WO-2005058916-A2 | ORGANOMETALLIC TRANSITION METAL COMPOUND, BISCYCLOPENTADIENYL LIGAND SYSTEM, CATALYST SYSTEM AND PREPARATION OF POLYOLEFINS | BASELL POLYOLEFINE GMBH (DE) | 2005-06-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070155919-A1 | Organometallic transition metal compound, biscyclopentadienyl ligand system, catalyst system and preparation of polyolefins | SOD1, ORC3, OPRM1 | CES1 1245/4885MEN1 1044/4885KMT2A 3460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.